The largest database of trusted experimental protocols

5 protocols using at 101

1

Cell Proliferation Assay with CDDP and AT-101

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was measured using the Cell Counting Kit-8 assay (Beyotime Inc., Haimen, Jiangsu, People’s Republic of China), according to the manufacturer’s instructions. Briefly, cells were plated at a density of 8,000 per well on 96-well plates overnight, and then treated with CDDP alone (Jiangsu Hanson Pharmaceutical Co. Ltd., Lianyungang, Jiangsu, People’s Republic of China) or combined with AT-101 (Selleckchem Inc., Shanghai, People’s Republic of China). After culturing for 48 hours, cell viability was quantified by reading the plates at an absorbance of 490 nm on a microplate reader.
+ Open protocol
+ Expand
2

Genetic Manipulation of LDHA and LDHB

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 293T human embryonic kidney cell line, and PANC-1 and Capan-2 pancreatic cancer cell lines were purchased from the American Type Culture Collection and were previously tested for mycoplasma contamination. Cells were routinely cultured in Dulbecco’s Modified Eagle Medium (Macgene, China) with 10% fetal bovine serum (Hyclone, USA). The FLAG-tagged LDHB eukaryotic expression vector was generated by inserting PCR-amplified fragments of the LDHB gene into pcDNA3 (Invitrogen, USA). Lentiviral shRNA vectors of LDHA and LDHB were constructed by cloning short hairpin RNA fragments into pSIH-H1-Puro (System Biosciences, USA). Target sequences are as follows, LDHA shRNA: 5’- ATCCAGTGGATATCTTGACCTACG -3’; LDHB shRNA: 5’- GGATATACCAACTGGGCTATT -3’. Lentiviruses were produced by co-transfection of HEK293T cells with recombinant lentivirus vectors and pPACK Packaging Plasmid Mix (System Biosciences, USA) using PEI reagent (Polyscience, USA). Lentiviruses were used to infect target cells in accordance with the manufacturers’ instructions. Myc-TERT, Flag-TERT, and GST-TERT plasmids were described previously (15 (link)). Sodium pyruvate, Sodium lactate, Methyl pyruvate and IPTG were products from Sigma (USA). 2-DG and AT-101 were purchased from Selleck (USA).
+ Open protocol
+ Expand
3

Manipulation of BCL Family Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solutions (10 mM) of trametinib, ABT-199, ABT-263, AT-101, sabutoclax, and UMI-77 (Selleckchem, Houston, TX, USA) were prepared in DMSO and stored at −80 °C. Appropriate concentrations of each drug were prepared in DMSO prior to use. Cell lines were transfected with siRNAs to BCL-2 (ON-TARGETplus Human BCL2 SMARTpool; Dharmacon, Lafayette, CO, USA), BCL-XL (Hs_BCL2L1_2, QIAGEN, Hilden, Germany), MCL-1 (Hs_MCL1_6, QIAGEN), BIM (Hs_BCL2L11_5, QIAGEN), and BAD (Hs_BAD_3, QIAGEN) using 4D-Nucleofector system (Lonza, Basel, Switzerland). AllStars Negative Control siRNA (QIAGEN) was the negative control.
The BIM-GFP expression plasmid was constructed by cloning the human BIMEL cDNA (BCL2L11-001, ENST00000393256) into a pMCEF vector and moving the BamHI and AgeI restriction fragment into the pEGFP-N1 vector. The plasmid was transfected into SD1 cells using 4D-Nucleofector system (Lonza) and GFP+ cells were sorted by flow cytometry after 48 h.
+ Open protocol
+ Expand
4

Cytotoxic Effects of AT101 in Gastric Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
AT101 (Selleckchem Inc, Shanghai, China) was dissolved in DMSO with a stock concentration of 50 mM, and was freshly diluted to the desired concentrations with culture medium. The final concentration of DMSO was at 0.05% (v/v). The MTT assay was performed to examine the effect of AT101 on the viability of AGS and NCI-N87 cells. Briefly, cells were seeded in 96-well culture plates at a density of 8 × 103 cells/well. After attaching, we treated cells with AT101 at different concentrations (0.5–50 μM). The control cells received the vehicle only. After 24 hours incubation, 10 μL MTT (5 g/L) was added to each wells and cultured for 4 hours. Then, 100 μL DMSO was added in the plates. The absorbance at the 570 nm wavelength was measured with a Synergy H4 Hybrid microplate reader (BioTek Inc., Winooski, VT, USA). The IC50 values were analyzed using GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA, USA).
+ Open protocol
+ Expand
5

Apoptosis Regulating Compounds Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco's Modified Eagle's Medium (DMEM), trypsin-EDTA, penicillin-streptomycin and dimethyl sulfoxide (DMSO), MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (M2128), Hoechst 33258 (B1155), Crystal Violet (C0755), and DCF (D6883) were purchased from Sigma-Aldrich (St. Louis, MO). All tissue culture-ware was from Nunc (Roskilde, Denmark). Biotin Blocking System, peroxidase substrate (DAB) and peroxidase buffer were from DAKO (Glostrup, Denmark). Aquatex was from Merck (Darmstadt, Germany). The ABC kit was from Vecstain (Burlingame, CA). Proteinase inhibitors were from Roche (Madrid, Spain). ECL western blotting substrate was from Pierce (Thermo Fisher Scientific, Rockford, IL). BCL-2 siRNA (h) (sc-29214), BCL-xL siRNA (h) (sc-43630), MCL-1 siRNA (h) (sc-35877) and scrambled controls were purchased from Santa Cruz Biotechnology (Dallas, TX). Lipofectamine2000 (11668-027), Novex Sharp Pre-stained Protein Standard (LC5800) and JC-1 (T-3168) were from Invitrogen Life Technologies (Carlsbad, CA). Sorafenib (BAY 43-9006, Nexavar) and Regorafenib (BAY 73-4506, Stivarga) are manufactured by Bayer. A-1155463, ABT-737, AT101, HA-14, ABT-263 (Navitoclax) and ABT-199 (Venetoclax) were purchased from Selleckchem (Houston, TX).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!